Publications in collaboration with researchers from Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (22)

2024

  1. Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort

    Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 614-619

2023

  1. Down-Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon-γ Production

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 961-972

2021

  1. The trans-ancestral genomic architecture of glycemic traits

    Nature Genetics, Vol. 53, Núm. 6, pp. 840-860

2019

  1. Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Effects of amerindian genetic ancestry on clinical variables and therapy in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 44, Núm. 12, pp. 1804-1812

  2. Transancestral mapping and genetic load in systemic lupus erythematosus

    Nature Communications, Vol. 8

2016

  1. Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture

    Arthritis and Rheumatology, Vol. 68, Núm. 4, pp. 932-943

2009

  1. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2007

  1. Genetic association of IRF5 with SLE in Mexicans: Higher frequency of the risk haplotype and its homozygozity than Europeans

    Human Genetics, Vol. 121, Núm. 6, pp. 721-727

  2. No evidence of association between genetic variants of the PDCD1 ligands and SLE

    Genes and Immunity, Vol. 8, Núm. 1, pp. 69-74

2005

  1. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort

    Arthritis and Rheumatism, Vol. 52, Núm. 4, pp. 1138-1147

  2. Shared autoimmunity: The concept and introduction

    Autoimmunity

2004

  1. Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: A unifying hypothesis

    Genes and Immunity, Vol. 5, Núm. 2, pp. 130-137

2002

  1. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31

    American Journal of Human Genetics, Vol. 71, Núm. 5, pp. 1060-1071

  2. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

    Nature Genetics, Vol. 32, Núm. 4, pp. 666-669

2000

  1. Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families

    Genes and Immunity, Vol. 1, Núm. 6, pp. 380-385

  2. Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus

    Genomics, Vol. 70, Núm. 3, pp. 307-314

1999

  1. A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups

    Journal of Autoimmunity

1997

  1. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes

    Revista de Investigacion Clinica, Vol. 49, Núm. 3, pp. 171-178

1991

  1. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2

    Journal of Autoimmunity, Vol. 4, Núm. 6, pp. 935-945